Kenwood Management Company Completes 9800 SF Lease With Straughan Environmental in Columbia, Maryland

Kenwood Quarry LLC, an affiliate of Kenwood Management Company, a mid-Atlantic commercial property owner-manager, announced today that it had completed a 9,800 sf, 7-year lease with Straughan Environmental, a leading engineering and environmental firm advancing sustainable & resilient communities.

Kenwood was represented by Charles Breitenother and Austin Eber from KLNB. Straughan was represented by Scott Matthews from Cushman & Wakefield.

Straughan, an award-winning environmental engineering firm is committed to developing sustainable solutions by considering the social, economic, and natural environments while challenging standard approaches and considering unique applications of emerging technologies. Straughan engineers strive to demonstrate that sustainable solutions are the better option for fiscal responsibility, long-term resiliency, and community satisfaction.

Located at 9175 Guilford Road in Columbia, Maryland, Kenwood purchased Quarry Pond Overlook in 2021. The three-story office building overlooks a large quarry, which is surrounded by mature trees. The office building also features a large deck overlooking the pond for tenants to enjoy. Conveniently located off of Maryland Route 32 and sandwiched between Maryland Route 29 and Interstate I-95, Quarry Pond Overlook is also near Fort Meade.

Commercial Interior Construction has been awarded a contract to improve the space for Straughan. They are expected to occupy their new corporate headquarters in June.

Tom Driscoll, Asset Manager from Kenwood, said, ”We are very excited to welcome Straughan to Quarry Pond Overlook. The property’s unique setting is a perfect match with Straughan’s company goals to promote sustainable work environments.”

Quarry Pond Overlook currently has two suites available. One is 868 sf and the other is 9186 sf, which can be subdivided.

About Kenwood Management

Kenwood Management is a privately held owner-operator of a 1.4 million square foot portfolio of office, medical, flex, and warehouse properties in the Washington, D.C., and Baltimore markets. With a unique private equity model, Kenwood combines its own sponsor equity with investments from high-net-worth individuals, enabling co-investors to participate in long-term, stable, cash-flowing commercial real estate opportunities.

Headquartered in Bethesda, MD, Kenwood has been delivering consistent investment performance for over 25 years. The company’s success is driven by its disciplined acquisition strategy, focusing on multi-tenant properties in prime locations that provide diversification, reduced vacancy risks, and reliable cash flow.

For more information about Kenwood Management and its investment opportunities, visit www.kenwoodmgt.com.

Media Contact
Company Name: Kenwood Management Company
Contact Person: Bill Singer
Email: Send Email
Country: United States
Website: https://www.kenwoodmgt.com/

Metastatic Prostate Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

DelveInsight’s, “Metastatic Prostate Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies and 85+ pipeline drugs in metastatic prostate cancer pipeline landscape. It covers the Metastatic Prostate Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metastatic Prostate Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Stay ahead with the latest insights! Download DelveInsight’s comprehensive Metastatic Prostate Cancer Pipeline Report to explore emerging therapies, key Metastatic Prostate Cancer Companies, and future Metastatic Prostate Cancer treatment landscapes @ Metastatic Prostate Cancer Pipeline Outlook Report

Key Takeaways from the Metastatic Prostate Cancer Pipeline Report

  • In February 2025:- Bayer:- This study is a phase III multinational, multicenter,randomized, double blind, placebo controlled, study with a randomization allocation ratio of 1:1 (radium-223 dichloride plus abiraterone acetate plus prednisone/prednisolone: placebo plus abiraterone acetate plus prednisone/prednisolone). Until the final overall survival (OS) analysis, the study period consisted of screening / randomization, treatment, active follow-up with clinic visits, active follow-up without clinic visits, and longterm follow-up phases.
  • In February 2025:- AstraZeneca:- This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of AZD5305 when given in combination with new hormonal agents (NHAs) in patients with Metastatic Prostate Cancer. The study consists of 2 parts, Part A and Part B. Part A consists of the dose escalation cohorts and will include patients with metastatic castration resistant prostate cancer (mCRPC) or metastatic castration-sensitive prostate cancer (mCSPC); Part B consists of dose expansion cohorts and will include patients with mCSPC only.
  • In February 2025:- Novartis Pharmceuticals:– The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care, versus Standard of Care alone, in adult male patients with mHSPC. In this study, the SoC is defined as a combination of Androgen Receptor Directed Therapy + Androgen Deprivation Therapy. Approximately 1126 patients will be randomized in this study. As of 31-Jan-2024, 1144 participants have been enrolled in 20 countries.
  • In February 2025:- Aragon Pharmaceuticals Inc.:– This Phase 3 clinical trial is an essential step in the evaluation of an investigational medication to see if it may be useful in treating prostate cancer. The purpose of the SPARTAN study is to compare the safety and effectiveness of the investigational medication to placebo in delaying prostate cancer from spreading to other parts of the body. A placebo is a pill that looks like the investigational medication but does not contain any active medication, a dummy pill.
  • In February 2025:- Janssen Research & Development LLC:- The purpose of this study is to determine if newly diagnosed (within previous 3 months) participants with metastatic (spread of cancer cells from one part of the body to another ) hormone-naive prostate cancer (mHNPC) who have high-risk prognostic factors will benefit from the addition of abiraterone acetate plus low-dose prednisone to androgen deprivation therapy (ADT; lutenizing hormone releasing hormone [LHRH] agonists or surgical castration).
  • In February 2025:- Halda Therapeutics OpCo Inc.:- This is a Phase 1/2, open-label study of the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and anti-tumor activity of oral single-agent HLD-0915. Patients on the study must continue androgen deprivation therapy (ADT) unless surgically castrated.
  • DelveInsight’s Metastatic Prostate Cancer pipeline report depicts a robust space with 80+ active players working to develop 85+ pipeline therapies for Metastatic Prostate Cancer treatment.
  • The leading Metastatic Prostate Cancer Companies such as Tavanta Therapeutics, Cardiff Oncology, Oncternal Therapeutics, Valerio Therapeutics, ORIC Pharmaceuticals, Telix Pharmaceuticals (Innovations) Pty Limited, Orion Corporation, OncoC4 Inc., Bristol-Myers Squibb/Ono Pharmaceuticals, Janssen Research & Development LLC, Merck Sharp & Dohme LLC, Modra Pharmaceuticals, Minneamrita Therapeutics LLC, AB Science, Cellbion Co., Ltd., Allarity Therapeutics, Janssen Research & Development, LLC, Hansoh BioMedical R&D Company, Jiangsu HengRui Medicine Co., Ltd., Hinova Pharmaceuticals Inc., ValiRx Plc, Epizyme Inc., Astrazeneca, and others.
  • Promising Metastatic Prostate Cancer Therapies such as Androgen Deprivation Therapy, Docetaxel, Nivolumab, Tazemetostat, Abiraterone/prednisone, Enzalutamide, and others.

Discover how the Metastatic Prostate Cancer treatment paradigm is evolving. Access DelveInsight’s in-depth Metastatic Prostate Cancer Pipeline Analysis for a closer look at promising breakthroughs @ Metastatic Prostate Cancer Clinical Trials and Studies

Metastatic Prostate Cancer Emerging Drugs Profile

  • TAVT-45: Tavanta Therapeutics

TAVT-45 is a novel oral suspension of abiraterone acetate. It was designed as an alternative abiraterone acetate formulation with clear benefits over branded Zytiga tablets. TAVT-45 granules are rapidly reconstituted in water or juice and easily consumed, which could aid the ~20-30% of patients who have dysphagia or difficulty swallowing.5,6 In clinical studies with TAVT-45, variability in abiraterone exposure was reduced compared to Zytiga, and bioavailability was enhanced in subjects in a fasted state. The improved absorption profile allows for a reduction in the total daily dose of TAVT-45 compared to Zytiga and may potentially improve exposure to therapeutic abiraterone concentrations over 24 h. The large food effect of Zytiga is also avoided, and it is anticipated TAVT-45 to be dosed without regard to meals.

  • Onvansertib: Cardiff Oncology

Onvansertib is a first-in-class, third-generation, oral and highly-selective adenosine triphosphate (ATP) competitive inhibitor of the serine/threonine polo-like-kinase 1 (PLK1) enzyme, which is over-expressed in multiple cancers including leukemias, lymphomas and solid tumors. Onvansertib targets the PLK1 isoform only (not PLK2 or PLK3), is orally administered and has a 24-hour half-life with only mild-to-moderate side effects reported. Currently, the drug is in Phase II stage of its development for the treatment of prostate cancer.

  • ONCT-534: Oncternal Therapeutics

ONCT-534, Dual-Action Androgen Receptor Inhibitor (DAARI) candidate, is a novel investigational, potentially first-in-class, orally bioavailable, dual-action androgen receptor (AR) inhibitor, designed to treat patients with metastatic castration-resistant prostate cancer and other androgen receptor-driven diseases. Currently, the drug is in Phase I/II stage of its development for the treatment of prostate cancer.

  • VIO-01: Valerio Therapeutics

VIO-01 is designed to abrogate several DNA repair pathways and trigger a robust immune response by activating the innate immune response through the STING pathway. The STING pathway plays a critical role in detecting DNA abnormalities and activating the immune system to target and destroy cancer cells. VIO-01 is currently undergoing proof-of-concept IND-enabling preclinical studies, alone and in combination with cancer immunotherapies. Currently, the drug is in Phase I/II stage of its development for the treatment of prostate cancer.

  • ORIC-944: ORIC Pharmaceuticals

ORIC-944 is a potent, orally bioavailable, highly selective allosteric small molecule inhibitor of PRC2, the complex which tri-methylates histone H3 lysine 27 (H3K27me3) via targeting the embryonic ectoderm development (EED) subunit. Currently, the drug is in Phase I stage of its development for the treatment of prostate cancer.

The Metastatic Prostate Cancer pipeline report provides insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Metastatic Prostate Cancer with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Metastatic Prostate Cancer Treatment.
  • Metastatic Prostate Cancer Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Metastatic Prostate Cancer Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Metastatic Prostate Cancer market.

Get a detailed analysis of the latest innovations in the Metastatic Prostate Cancer pipeline. Explore DelveInsight’s expert-driven report today! @ Metastatic Prostate Cancer Unmet Needs

Metastatic Prostate Cancer Companies

Pharmaceuticals, Telix Pharmaceuticals (Innovations) Pty Limited, Orion Corporation, OncoC4 Inc., Bristol-Myers Squibb/Ono Pharmaceuticals, Janssen Research & Development LLC, Merck Sharp & Dohme LLC, Modra Pharmaceuticals, Minneamrita Therapeutics LLC, AB Science, Cellbion Co., Ltd., Allarity Therapeutics, Janssen Research & Development, LLC, Hansoh BioMedical R&D Company, Jiangsu HengRui Medicine Co., Ltd., Hinova Pharmaceuticals Inc., ValiRx Plc, Epizyme Inc., Astrazeneca, and others.

Metastatic Prostate Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Oral
  • Intravenous
  • Subcutaneous
  • Parenteral
  • Topical

Metastatic Prostate Cancer Products have been categorized under various Molecule types such as

  • Recombinant fusion proteins
  • Small molecule
  • Monoclonal antibody
  • Peptide
  • Polymer
  • Gene therapy

Download DelveInsight’s latest report to gain strategic insights into upcoming Metastatic Prostate Cancer Therapies and key Metastatic Prostate Cancer Developments @ Metastatic Prostate Cancer Market Drivers and Barriers, and Future Perspectives

Scope of the Metastatic Prostate Cancer Pipeline Report

  • Coverage- Global
  • Metastatic Prostate Cancer Companies- Tavanta Therapeutics, Cardiff Oncology, Oncternal Therapeutics, Valerio Therapeutics, ORIC Pharmaceuticals, Telix Pharmaceuticals (Innovations) Pty Limited, Orion Corporation, OncoC4 Inc., Bristol-Myers Squibb/Ono Pharmaceuticals, Janssen Research & Development LLC, Merck Sharp & Dohme LLC, Modra Pharmaceuticals, Minneamrita Therapeutics LLC, AB Science, Cellbion Co., Ltd., Allarity Therapeutics, Janssen Research & Development, LLC, Hansoh BioMedical R&D Company, Jiangsu HengRui Medicine Co., Ltd., Hinova Pharmaceuticals Inc., ValiRx Plc, Epizyme Inc., Astrazeneca, and others.
  • Metastatic Prostate Cancer Therapies- Androgen Deprivation Therapy, Docetaxel, Nivolumab, Tazemetostat, Abiraterone/prednisone, Enzalutamide, and others.
  • Metastatic Prostate Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Metastatic Prostate Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Which companies are leading the race in Metastatic Prostate Cancer drug development? Find out in DelveInsight’s exclusive Metastatic Prostate Cancer Pipeline Report—access it now! @ Metastatic Prostate Cancer Emerging Drugs and Major Companies

Table of Content

  1. Introduction
  2. Executive Summary
  3. Metastatic Prostate Cancer: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Metastatic Prostate Cancer– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. TAVT-45: Tavanta Therapeutics
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. Onvansertib: Cardiff Oncology
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I/II)
  14. VIO-01: Valerio Therapeutics
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. Drug name: Company name
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Metastatic Prostate Cancer Key Companies
  21. Metastatic Prostate Cancer Key Products
  22. Metastatic Prostate Cancer- Unmet Needs
  23. Metastatic Prostate Cancer- Market Drivers and Barriers
  24. Metastatic Prostate Cancer- Future Perspectives and Conclusion
  25. Metastatic Prostate Cancer Analyst Views
  26. Metastatic Prostate Cancer Key Companies
  27. Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/knee-reconstruction-devices-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Metastatic Prostate Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

myBVICharter Proudly Presents Award-Winning Charter Yachts in the British Virgin Islands

myBVICharter, with operational headquarters in both the British Virgin Islands and the U.S. Virgin Islands, is a leading yacht charter company that boasts an impressive fleet of over 400 yachts. Operating under the umbrella of DMA Yachting, the renowned charter company is thrilled to introduce its portfolio of award-winning charter yachts offering unparalleled levels of luxury and individualized experiences in the breathtaking British Virgin Islands (BVI).

The British Virgin Islands is known for its crystal-clear waters, secluded beaches, and vibrant marine life, making it a haven for sailing enthusiasts and lovers of luxury alike. myBVICharter strives to make each voyage an unforgettable adventure with excellent service and customized itineraries. From power catamarans to sleek motor yachts, myBVICharter’s award-winning fleet features a diverse range of vessels tailored to meet the preferences of discerning travelers

Showcasing a selection of myBVICharter’s Award-Winning Yachts

OLIVIA CHARLESCatamaran: This spacious crewed catamaran has four cabins, perfect for eight guests. It features plenty of seating and even a small bar, making it perfect for relaxing.

According to myBVICharter, Olivia Charles Catamaran swept the awards at the 2024 BVI Yacht Show, taking home 1st Place for Best Designer Water, 1st Place for Best Dessert, and Runner-Up for Best Yacht in Show (54-59 ft). “Emma Clark’s Designer Water won 1st Place in the Best Designer Water Competition at the BVI Yacht Show 2024. Her award-winning water was served in a martini glass with fresh mint, a giant ice cube slowly releasing fruity sweetness, and a bubble on top that popped with a delicate puff of smoke,” said Daniel Asmus, owner of DMA Yachting.

OMAKASE—Power Catamaran: This impressive 68-foot charter yacht, which placed 1st Place for Best Motor Yacht in Show, is classified primarily as a power catamaran. It features 3 generous cabins with stylish décor, great ensuite facilities, and unbeatable views in the morning, easily accommodating a group of 6 guests. Its massive flybridge is well-protected, has a balcony towards the bow, and a big aft deck with sunbeds. Moreover, there are a variety of seating areas where guests can spend most of their time.

ANGELEYES—Motor Yacht: This stunning yacht has won many awards on Netflix. According to the company, Angeleyes is amazing not just because of its beauty but also because of the overall experience created by the fantastic crew. Angeleyes is the perfect choice for guests looking to experience the most fun and luxury possible on a Caribbean charter.

myBVICharter, powered by DMA Yachting, proudly boasts an impressive 4.9-star customer satisfaction rating on Trust Point. Customers consistently praise the seamless booking process, the exceptional staff, the unforgettable experiences, the personalized itineraries, the diverse fleet of luxury yachts, and the breathtaking destinations. This outstanding rating is a true reflection of myBVICharter’s commitment to excellence and delivering world-class yachting adventures.

The yacht charter company values the way it does business, with transparency and honesty at the center of its core. “We are who we are today because of our incredible customers. Our goal is to make everyone’s experience unforgettable,” added Daniel Asmus.

myBVICharter offers attentive customer service, smooth and straightforward booking, and an attentive and professional team. myBVICharter’s positive feedback points out its dedication to making yacht charting approachable and without headaches for its adventurous travelers.

Please visit myBVICharter’s website for more details on its award-winning charters or to reserve any of its exclusive crewed or captain-only charters.

About myBVICharter

Powered by DMA Yachting, myBVICharter is a leading provider of yacht charters in the British Virgin Islands and the U.S. Virgin Islands. With an aim for excellence and a passion for delivering memorable experiences to its customers, the company works with an extensive network of suppliers that offer various exclusive yacht options to cater to every traveler’s unique preference and budget. myBVICharter’s professional team is adept at scrutinizing every aspect of a yacht to ensure it meets its high standards. They also assess the flexibility of the menu, the dynamics among the crew, and how family-friendly the yacht is. Focusing on attention to detail and exceptional customer satisfaction, myBVICharter yacht charter continues to set the benchmark for excellence in the yacht charter industry.

Media Contact
Company Name: MyBVICharter
Contact Person: Daniel Asmus
Email: Send Email
Country: United States
Website: https://mybvicharter.com/

Maffra Cheese Company Announces Exciting New Direct-to-Consumer Model

Renowned Australian cheesemaking company Maffra Cheese Company is happy to announce the introduction of a new direct-to-consumer model scheduled for later this year. This strategic project will provide cheese lovers all around direct access to the award-winning range of the company, therefore strengthening its dedication to provide top quality cheeses right from the farm to the consumer’s table.

Maffra Cheese Company opened in 1870 and has always been the leading edge in Australian cheesemaking. The firm started at Gibney’s Hotel, where a group of farmers set up one of Australia’s first “automated” cheese manufacturers. Under the direction of renowned cheesemaker and chemist Ferial Zekiman today, Maffra keeps creating some of the best cheeses in the nation. Zekiman, awarded an Order of Australia in 2016 for her efforts in the dairy sector, has helped maintain the company’s high standards.

From farm to plate, Maffra Cheese Company supervises every element of the cheesemaking process to guarantee that every product reflects the company’s dedication to excellence. The cows live in a clean, low-stress environment and their feed and pasture are carefully turned to keep ideal milk quality all year long. This emphasis on sustainable methods and quality control produces cheeses reflecting the special seasonal character of the farm in addition to being quite delicious.

The new direct-to-consumer approach will make Maffra’s handcrafted cheeses more easily available to consumers so they can quickly order their preferred items online. Maffra’s cheeses will be ready with just a few clicks, whether for thoughtful presents or entertaining visitors. As it is ready to present the best cheeses from Gippsland straight to homes all around, the company asks cheese-lovers to stay tuned for further information.

About Maffra Cheese Company

Based in Gippsland, Victoria, Maffra Cheese Company has received many international medals for artisan cheeses. The business is still committed to creating premium seasonal cheeses that honor Australia’s rich cheesemaking past.

Media Contact
Company Name: Maffra Cheese Company
Contact Person: Jack
Email: Send Email
Country: Australia
Website: https://maffra.designpointstaging.com.au/

Bunker Fuel Market is Anticipated is Reach $181.64 Billion by 2032 with a Steady CAGR of 4.30%

“Bunker Fuel Market”
Bunker fuel is a mixture of fuel oils used in marine vessels to keep engines running. It is poured into the ship’s bunkers and can be in several forms, including high-sulfur fuel oil, low-sulfur fuel oil, and diesel oil.

The bunker fuel market, a critical component of the global maritime industry, has undergone significant transformations in recent years. Driven by regulatory changes, environmental concerns, and shifting energy dynamics, the market for bunker fuel—the fuel used by ships—has seen both challenges and opportunities emerge.

Bunker fuel Market Size was valued at USD 124.35 billion in 2023. The Bunker fuel industry is projected to grow from USD 129.69 Billion in 2024 to USD 181.64 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.30 % during the forecast period (2024 – 2032).

Bunker fuel is the lifeblood of the shipping industry, powering vessels that transport over 80% of global trade by volume. Traditionally, the market has been dominated by heavy fuel oil (HFO), a residual product of crude oil refining. However, the introduction of the International Maritime Organization’s (IMO) 2020 sulfur cap regulation marked a turning point for the industry. The regulation limited the sulfur content in marine fuels to 0.5%, down from the previous 3.5%, forcing shipowners to adopt cleaner fuels or install exhaust gas cleaning systems (scrubbers).

The market is segmented into various fuel types, including:

  1. Very Low Sulfur Fuel Oil (VLSFO): The most widely used bunker fuel post-IMO 2020, VLSFO has become the standard for compliance with sulfur regulations.
  2. Marine Gas Oil (MGO): A distillate fuel with low sulfur content, MGO is used primarily in emission control areas (ECAs).
  3. High Sulfur Fuel Oil (HSFO): Still used by vessels equipped with scrubbers, HSFO remains a cost-effective option for some shipowners.
  4. Alternative Fuels: Liquefied natural gas (LNG), biofuels, methanol, and hydrogen are gaining traction as the industry seeks to reduce greenhouse gas emissions.

 

Market Segmentation

The global bunker fuel market has been segmented into fuel, application, and seller.

Based on fuel, the market has been segmented into high-sulfur fuel oil (HSFO), very-low-sulfur fuel oil (VLSFO), marine diesel oil (MDO), and liquefied natural gas (LNG). The very-low sulfur fuel oil (VLSFO) segment accounted for the largest share of the market in 2025. It is sensitive to the environment. It only has a 0.1% sulfur content. Most ship owners have selected it as the proper fuel after considering environmental restrictions and emission standards. The growth of worldwide commerce has increased the demand for marine gasoline. The most cost-effective alternative is bunker fuel, which supports the maritime sector. On the other hand, the marine diesel oil (MDO) segment was the fastest-growing segment during the forecast period owing to its cheapest cost.

Based on application, the market has been segmented into bulk & general cargo fleet, tanker fleet, container fleet, and others (including passenger ferries and cruise ships). The container fleet accounted for the largest revenue share in 2025 in the bunker fuel market. The rise in trade-related agreements and the demand for cargo transportation via ships explains this. The tanker fleet was the fastest-growing segment because most of the transportation of goods was carried out through bulk and general cargo vessels.

Based on seller, the market has been segmented into major oil companies, leading independent sellers, and small independent sellers. The major oil companies segment accounted for the largest revenue share in 2025 in the market for bunker fuel. The global hegemony of the oil majors in chartering crude oil tankers is credited with this expansion. On the other hand, leading independent sellers was the fastest-growing segment. These distributors have a variety of physical assets, including storage terminals and blending facilities in significant bunkering ports. They can outperform smaller independent distributors because of this.

 

Get Report Sample Copy: https://www.marketresearchfuture.com/sample_request/10871

 

Key Companies in the Bunker fuel market include

 

Chemoil Energy Limited (Hong Kong)

Aegean Marine Petroleum Network, Inc. (Switzerland)

World Fuel Services Corporation (US)

Gulf Agency Company Ltd. (Dubai)

Gazpromneft Marine Bunker LLC (Russia)

BP Marine Ltd. (UK)

 

Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=10871

 

Company News and Developments

Shell’s Expansion into LNG Bunkering Shell, one of the world’s largest bunker fuel suppliers, has been at the forefront of the transition to cleaner fuels. In 2023, the company announced plans to expand its LNG bunkering infrastructure, with new facilities in key ports across Europe and Asia. Shell has also partnered with major shipping companies to promote the adoption of LNG as a marine fuel.

BP’s Investment in Biofuels BP has been actively investing in biofuels as part of its strategy to decarbonize the shipping industry. In early 2023, the company launched a new biofuel blend specifically designed for marine use. The blend, which combines traditional bunker fuel with sustainable biofuels, has been well-received by shipowners seeking to reduce their carbon emissions.

Maersk’s Methanol-Powered Vessels Danish shipping giant Maersk has made headlines with its commitment to methanol as a sustainable fuel. In 2023, the company took delivery of its first methanol-powered container ship, marking a significant milestone in the industry’s transition to alternative fuels. Maersk has also signed agreements with fuel producers to secure a steady supply of green methanol.

TotalEnergies’ Digital Bunkering Platform TotalEnergies has launched a digital platform to simplify the bunker fuel procurement process. The platform, which uses blockchain technology, allows shipowners to track fuel deliveries in real-time and verify the quality and quantity of fuel received. This innovation is expected to enhance transparency and reduce disputes in the bunker fuel market.

Chevron’s Collaboration on Hydrogen Fuel Chevron has partnered with several technology companies to explore the potential of hydrogen as a marine fuel. In 2023, the company announced a pilot project to test hydrogen fuel cells on a commercial vessel. While hydrogen is still in the early stages of development for maritime use, it holds promise as a zero-emission fuel for the future.

 

Related Report

Automotive Coolant Market Research Report – Global Forecast by 2034

Fluorspar Market Research Report – Global Forecast by 2034

Syngas Market Research Report – Global Forecast by 2034

Sodium Methylate Market Research Report – Global Forecast by 2034

Coal Tar Pitch Market Research Report – Global Forecast by 2034

Ultra-Fine Copper Powder (99.9999%) Market Research Report – Global Forecast by 2034

 

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. The MRFR team have a supreme objective to provide the optimum quality market research and intelligence services for our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,

5Th Floor, New York,

New York 10013

United States of America +1 628 258 0071

Email: sales@marketresearchfuture.com

 

 

Media Contact
Company Name: Market Research Future
Contact Person: Media Relations
Email: Send Email
Country: United States
Website: https://www.marketresearchfuture.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Bunker Fuel Market is Anticipated is Reach $181.64 Billion by 2032 with a Steady CAGR of 4.30%

Marine Battery Market Size USD 2.0 Billion By at CAGR 16.83 % (2024-2032) Due to Increasing Maritime Tourism Industry Growth.

Marine Battery Market Research Report Information By Type (Valve-regulated Lead Acid, Batteries, Flooded Lead Acid Batteries And Others), By Application (Marine Starting Service, Deep Cycle Service and Dual-Purpose Service), By Ship Type (Commercial And Defense), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032.

Global Marine Battery Market Overview

The marine battery market is undergoing a significant transformation driven by the increasing adoption of electric propulsion systems, stringent environmental regulations, and advancements in battery technology. As the maritime industry shifts towards sustainable and energy-efficient solutions, marine batteries are emerging as a critical component in reducing carbon emissions and improving vessel performance. The Marine Battery Market is expected to expand from USD 0.576 billion in 2024 to USD 2.0 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of 16.83%.

 

Get a Quote – Request a price quote for the report or specific research services.

The global marine battery market is witnessing substantial growth, primarily fueled by the increasing demand for electric and hybrid vessels. The rise in global trade and the need for energy-efficient marine transportation solutions have propelled the adoption of advanced battery technologies. Marine batteries are used in various applications, including propulsion systems, backup power, and auxiliary power support. With governments and regulatory bodies enforcing stringent emission norms, the transition from conventional fuel-powered vessels to electric and hybrid alternatives is gaining momentum.

Competitive Landscape

The marine battery market is highly competitive, with key players investing in research and development to enhance battery performance and expand their product portfolios. Some of the leading companies in the industry include Major players in the Marine Battery Market, including HBL Power Systems Limited (India), Korea Special Battery (South Korea), Manbat Ltd (UK), Saft Groupe SA (France), Systems Sunlight SA (Greece) and others, are attempting to increase market demand by investing in research and development operations.

Key Drivers of Market Growth

  • Stringent Environmental Regulations: The International Maritime Organization (IMO) and other regulatory bodies have implemented strict emission norms to reduce greenhouse gas emissions from the maritime sector. These regulations have encouraged shipbuilders and operators to invest in cleaner propulsion systems, thereby driving the demand for marine batteries.
  • Rising Adoption of Electric and Hybrid Vessels: The increasing adoption of electric and hybrid vessels, particularly in commercial, recreational, and defense applications, is a key factor boosting the marine battery market. Electric propulsion offers advantages such as reduced fuel consumption, lower maintenance costs, and minimal environmental impact.
  • Advancements in Battery Technology: Continuous improvements in battery technologies, including lithium-ion, solid-state, and fuel-cell-based solutions, have enhanced the efficiency, durability, and energy density of marine batteries. These advancements are making electric and hybrid vessels more viable for long-range operations.
  • Growing Investments in Renewable Energy: The integration of renewable energy sources such as solar and wind power with marine battery systems is gaining traction. Hybrid solutions that utilize renewable energy help optimize fuel efficiency and operational costs for shipping companies.

Market Segmentation

The marine battery market can be segmented based on type, application, and region.

  • By Type: The market includes lithium-ion, lead-acid, nickel-cadmium, and other battery types. Lithium-ion batteries dominate the market due to their high energy density, longer lifespan, and faster charging capabilities.
  • By Application: The market is categorized into commercial vessels, Défense vessels, recreational boats, and underwater vehicles. The commercial segment holds the largest share due to the increasing adoption of hybrid and electric ships for cargo and passenger transport.
  • By Region: The market is analysed across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Europe and Asia-Pacific are leading the market due to strong government support, high investments in green shipping solutions, and a robust shipbuilding industry.

Challenges Facing the Market

Despite its promising growth, the marine battery market faces several challenges:

  • High Initial Investment Costs: The upfront costs of battery-powered vessels and hybrid systems are relatively high compared to traditional fuel-based ships. This factor may hinder adoption, particularly among smaller fleet operators.
  • Battery Performance and Longevity: While advancements have improved battery efficiency, concerns regarding lifespan, energy density, and safety persist. Battery degradation over time can impact vessel operations and lead to higher maintenance costs.
  • Lack of Charging Infrastructure: The availability of charging stations in ports and along shipping routes remains a significant barrier. Expanding charging infrastructure is crucial to support the widespread adoption of electric and hybrid marine vessels.

Buy Now – Take immediate action to purchase the full report and access all the valuable information it contains.

Future Outlook and Trends

The future of the marine battery market looks promising, with several trends shaping its growth:

  • Expansion of Electric Ferries and Passenger Vessels: Governments worldwide are promoting electric ferries and passenger boats to reduce urban waterway pollution. Countries such as Norway and Sweden are leading the way in deploying electric ferries.
  • Development of Solid-State Batteries: Solid-state battery technology is expected to revolutionize the marine industry by offering higher energy density, improved safety, and longer lifespan compared to traditional lithium-ion batteries.
  • Increased Integration of AI and IoT: The use of artificial intelligence (AI) and the Internet of Things (IoT) in battery management systems is expected to optimize battery performance, enhance predictive maintenance, and improve energy efficiency.
  • Government Incentives and Subsidies: Many governments are providing subsidies and incentives to encourage the adoption of clean energy solutions in the maritime sector. These policies will further accelerate the transition to battery-powered marine vessels.

Conclusion

The marine battery market is set for substantial growth, driven by regulatory pressures, technological advancements, and the push for sustainability in the maritime industry. While challenges such as high costs and infrastructure limitations remain, ongoing innovations and government support are expected to drive the adoption of marine batteries. As the industry evolves, stakeholders must focus on enhancing battery efficiency, expanding charging infrastructure, and promoting clean energy integration to ensure a greener and more sustainable future for marine transportation.

Frequently Asked Questions (FAQ):

How much is the Marine Battery Market?

The Marine Battery Market size was valued at USD 0.48 Billion in 2023.

What is the growth rate of the Marine Battery Market? The market is projected to grow at a CAGR of 16.83% during the forecast period, 2024-2032.

Which region held the largest market share in the Marine Battery Market? North America had the largest share in the market.

 

Discover More Research Reports on Aerospace & Defence by Market Research Future:

Commercial Aircraft Windows and Windshield Market Research Report – Global Forecast till 2030

Military Electro-Optical and Infrared Systems Market Research Report – Global Forecast till 2030

CBRN Défense Market Research Report- Global Forecast to 2030

Military Airborne Collision Avoidance Systems Market Research Report- Global Forecast to 2030

Military Aircraft Digital Glass Cockpit Systems Market Research Report Global Forecast till 2030

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor New York,

10013 United States of America+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: info@marketresearchfuture.com

Follow Us: LinkedIn | Twitter

Website: https://www.marketresearchfuture.com/

Media Contact
Company Name: Market Research Future
Contact Person: Media Relations
Email: Send Email
Country: United States
Website: https://www.marketresearchfuture.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Marine Battery Market Size USD 2.0 Billion By at CAGR 16.83 % (2024-2032) Due to Increasing Maritime Tourism Industry Growth.

Metastatic Liver Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

DelveInsight’s, “Metastatic Liver Cancer Pipeline Insight” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Metastatic-Liver-Cancer pipeline landscape. It covers the Metastatic Liver Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metastatic Liver Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Stay ahead with the latest insights! Download DelveInsight’s comprehensive Metastatic Liver Cancer Pipeline Report to explore emerging therapies, key Metastatic Liver Cancer Companies, and future Metastatic Liver Cancer treatment landscapes @ Metastatic Liver Cancer Pipeline Outlook Report

Key Takeaways from the Metastatic Liver Cancer Pipeline Report

  • In February 2025:- Alethia Biotherapeutics:- This Phase II study will recruit 17 colorectal cancerpatients with liver-dominant metastases. All recruited patients will receive Sotevtamab at a dose of 800 mg once weekly for 6 cycles combined with FOLFOX once every 2 weeks for the first 4 cycles followed by liver metastases resection surgery with or without primary cancer resection. One cycle of treatment will consist of 14 days (2 weeks).
  • In February 2025:- Medivir:- This is an open-label, multicentre dose escalation/expansion study to assess safety and tolerability of MIV 818 as either monotherapy or in combination with 1) lenvatinib, a tyrosine kinase inhibitor used as a standard of care for the treatment of HCC or 2) pembrolizumab, a PD-1 inhibitor. The monotherapy parts of the study will include patients with various solid tumours that have spread to the liver, or alternatively originating in the liver. Evaluations of MIV-818 in combination with lenvatinib or pembrolizumab will only include patients with HCC.
  • In February 2025:- Kamya Sankar:-This clinical trial aims to assess whether the addition of bevacizumab to atezolizumab and chemotherapy can improve response to treatment and progression-free survival in patients with extensive-stage small cell lung cancer (ES-SCLC) with liver metastases.
  • In February 2025:- Tango Therapeutics Inc.:- This is a first in human study in patients with advanced or metastatic solid tumors known to have an MTAP deletion. The first part of the study is an open-label, dose escalation and the second part is an open label dose expansion in specific MTAP-deleted tumor types. The study drug, TNG462, is a selective PRMT5 inhibitor administered orally. The study is planned to treat up to 225 participants.
  • In February 2025:- Bristol-Myers Squibb:- The purpose of this study is to evaluate the safety and effectiveness of triplet therapy of nivolumab, relatlimab and bevacizumab versus nivolumab and bevacizumab in participants with untreated advanced/metastatic hepatocellular carcinoma (HCC).
  • DelveInsight’s Metastatic Liver Cancer pipeline report depicts a robust space with 20+ active players working to develop 25+ pipeline therapies for Metastatic Liver Cancer treatment.
  • The leading Metastatic Liver Cancer Companies such as Oncorus, Sirnaomics, Codiak BioSciences, Sorrento Therapeutics, Inc., RemeGen Co., Ltd., Taiho Pharmaceutical Co., Ltd., Amarin Corporation, Eureka Therapeutics, Medivir AB, AstraZeneca, Amal Therapeutics, Boehringer Ingelheim, and others.
  • Promising Metastatic Liver Cancer Therapies such as ThermoDox® (LTLD), NV1020, Combretastatin A1 Diphosphate (OXi4503), Talaporfin sodium (LS11), CRS-100, EndoTAG®-1, AV-299, RO7119929, Tocilizumab, and others.

Discover how the Metastatic Liver Cancer treatment paradigm is evolving. Access DelveInsight’s in-depth Metastatic Liver Cancer Pipeline Analysis for a closer look at promising breakthroughs @ Metastatic Liver Cancer Clinical Trials and Studies

Metastatic Liver Cancer Emerging Drugs Profile

  • exoASO STAT6: Codiak BioSciences

exoASO™-STAT6 is an exosome therapeutic candidate engineered using our engEx™ Platform to overexpress Codiak’s novel protein scaffold, PTGFRN, to selectively target uptake in M2 polarized tumor-associated macrophages. Currently the drug is in Phase I stage of Clinical trial evaluation for the treatment of Metastatic-Liver-Cancer.

  • STP 705: Sirnaomics

STP705, is a dual TGF-ß1/COX-2 inhibitor. TGF-ß1 and COX-2 are well-validated gatekeeper targets for oncology and fibrosis disease drug development. STP705 leverages our locally administered PNP formulation for direct administration to diseased tissue. STP705 has received U.S. orphan drug designation for the treatment of certain hepatocellular carcinomas and liver fibrosis, including: primary sclerosing cholangitis (PSC), cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC). Currently the drug is in Phase I stage of Clinical trial evaluation for the treatment of Metastatic-Liver-Cancer.

  • ONCR 177: Oncorus

ONCR-177, our lead product candidate, is an intratumorally administered Herpes Simplex Virus (HSV) viral immunotherapy for the treatment of multiple solid tumor cancers. ONCR-177 fights tumors through multiple mechanisms, including inherent oncolytic activity, immune stimulation elicited by viral infection and the expression of five transgenes (IL-12, CCL4, FLT3LG, anti-PD-1 and anti-CTLA-4). Currently the drug is in Phase I stage of Clinical trial evaluation for the treatment of Metastatic-Liver-Cancer.

The Metastatic Liver Cancer pipeline report provides insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Metastatic Liver Cancer with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Metastatic Liver Cancer Treatment.
  • Metastatic Liver Cancer Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Metastatic Liver Cancer Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Metastatic Liver Cancer market.

Get a detailed analysis of the latest innovations in the Metastatic Liver Cancer pipeline. Explore DelveInsight’s expert-driven report today! @ Metastatic Liver Cancer Unmet Needs

Metastatic Liver Cancer Companies

Oncorus, Sirnaomics, Codiak BioSciences, Sorrento Therapeutics, Inc., RemeGen Co., Ltd., Taiho Pharmaceutical Co., Ltd., Amarin Corporation, Eureka Therapeutics, Medivir AB, AstraZeneca, Amal Therapeutics, Boehringer Ingelheim, and others.

Metastatic-Liver-Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Intra-articular
  • Intraocular
  • Intrathecal
  • Intravenous
  • Ophthalmic
  • Oral
  • Parenteral
  • Subcutaneous
  • Topical
  • Transdermal

Metastatic Liver Cancer Products have been categorized under various Molecule types such as

  • Oligonucleotide
  • Peptide
  • Small molecule

Download DelveInsight’s latest report to gain strategic insights into upcoming Metastatic Liver Cancer Therapies and key Metastatic Liver Cancer Developments @ Metastatic Liver Cancer Market Drivers and Barriers, and Future Perspectives

Scope of the Metastatic Liver Cancer Pipeline Report

  • Coverage- Global
  • Metastatic Liver Cancer Companies- Oncorus, Sirnaomics, Codiak BioSciences, Sorrento Therapeutics, Inc., RemeGen Co., Ltd., Taiho Pharmaceutical Co., Ltd., Amarin Corporation, Eureka Therapeutics, Medivir AB, AstraZeneca, Amal Therapeutics, Boehringer Ingelheim, and others.
  • Metastatic Liver Cancer Therapies- ThermoDox® (LTLD), NV1020, Combretastatin A1 Diphosphate (OXi4503), Talaporfin sodium (LS11), CRS-100, EndoTAG®-1, AV-299, RO7119929, Tocilizumab, and others.
  • Metastatic Liver Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Metastatic Liver Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Which companies are leading the race in Metastatic Liver Cancer drug development? Find out in DelveInsight’s exclusive Metastatic Liver Cancer Pipeline Report—access it now! @ Metastatic Liver Cancer Emerging Drugs and Major Companies

Table of Content

  1. Introduction
  2. Executive Summary
  3. Metastatic-Liver-Cancer: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Metastatic-Liver-Cancer– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. Drug name :Company Name
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. Drug name :Company Name
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I)
  14. ONCR 177: Oncorus
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. Drug name :Company Name
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Metastatic-Liver-Cancer Key Companies
  21. Metastatic-Liver-Cancer Key Products
  22. Metastatic-Liver-Cancer- Unmet Needs
  23. Metastatic-Liver-Cancer- Market Drivers and Barriers
  24. Metastatic-Liver-Cancer- Future Perspectives and Conclusion
  25. Metastatic-Liver-Cancer Analyst Views
  26. Metastatic-Liver-Cancer Key Companies
  27. Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/penile-implants-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Metastatic Liver Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

The U.S. Floral Gifting Market is Booming Worldwide, $16.81 Billion Worth Market by 2030 – Arizton

“U.S. Floral Gifting Market Research Report by Arizton”

According to Arizton’s latest research report, the U.S. floral gifting market is growing at a CAGR of 5.52% during 2024-2030.

        

Looking for More Information? Click: https://www.arizton.com/market-reports/floral-gifting-market-in-united-states-2025

 

Report Scope:        

Market Size (2030): $16.81 Billion  

Market Size (2024): $12.18 Billion  

CAGR (2024-2030): 5.52%  

Historic Year: 2021-2023  

Base Year: 2024  

Forecast Year: 2025-2030  

Market Segmentation: Occasion, Platform, Product, and Purchase Option

 

Market Overview

The US floral gifting market has experienced significant fluctuations, especially during recessionary periods, where high fees, penalties, and lack of innovation in distribution systems increased costs for consumers. Scarcity of fresh, sustainable flowers further hindered growth.

However, recent shifts indicate positive developments. Vendors are focusing on high-quality products, with start-ups driving innovation through on-demand production and farm-to-table systems. This has reduced waste and improved supply chain efficiency, resulting in sustainable practices.

The market has seen innovations in delivery and retail models, with the rise of e-commerce and improved delivery transparency. Additionally, there is a shift toward simpler, eco-friendly floral arrangements. Wholesale and retail consolidation, as well as direct farm-to-consumer sales, is disrupting the traditional supply chain.

New floral sources from countries like Nepal and Japan are diversifying the market, while challenges like marijuana legalization are impacting flower cultivation. To drive growth, vendors must focus on economies of scale and niche markets, capturing the evolving consumer interest in personalized, eco-conscious floral gifts.

 

The Role of Enhanced Logistics and Delivery in the Growth of the US Floral Gifting Market

Enhanced logistics and delivery services have played a key role in the growth of the US floral gifting market. To maintain customer satisfaction, companies have invested in advanced technologies, such as optimized delivery routes, specialized packaging, and real-time tracking, to ensure fresh and timely delivery. Notable examples, like 1-800-Flowers.com, have built robust logistics networks, including local florists and third-party distribution centers, offering same-day and next-day delivery options. The flower logistics industry has advanced with temperature-controlled storage, specialized transport methods, and global hubs, allowing flowers to be delivered efficiently. Moreover, modern technologies like process automation and digital platforms are improving efficiency and reducing costs. By optimizing logistics, vendors can manage demand fluctuations, reduce waste, and meet consumer needs while minimizing environmental impact, helping the market thrive amidst growing competition.

 

The Rise of the Farm-to-Table Movement Gaining Momentum

The farm-to-table movement, traditionally associated with the food sector, is increasingly influencing the floral industry. Rising costs, supply chain challenges, and a growing emphasis on sustainability are driving florists and consumers to prioritize seasonal, locally grown flowers. This shift promotes domestic flower farming and aligns with sustainability principles aimed at reducing carbon footprints and supporting local economies.

Molly Oliver Flowers, established in Brooklyn in 2012, exemplifies this movement by providing local, seasonal flowers for events, bouquets, and subscriptions. The business emphasizes sustainable practices by connecting customers with local growers. The Slow Flowers Society, through campaigns like American Flowers Week, advocates for domestic flower farming and eco-conscious floristry, promoting seasonal, locally sourced flowers through initiatives like the Botanical Couture collection.

Notable farms and florists embracing the farm-to-table approach include Crowley House Flower Farm, Resendiz Brothers Protea Growers, Grace Flowers Hawaii, PepperHarrow Farm, and Flori. These businesses prioritize local sourcing, sustainability, and reducing design waste, reflecting a broader shift in consumer preferences towards more sustainable, eco-friendly floral practices. Online florists are also focusing on minimizing supply chain expenses, shortening delivery times, and enhancing customer experiences.

The farm-to-table movement in the floral industry emphasizes design waste reduction, sustainable sourcing, and premium delivery, marking a significant trend toward sustainability in the U.S. floral market.

 

Mergers And Acquisitions

  • 1-800-Flowers.com acquired Things Remembered in January 2023, a retailer selling engraved gifts. The company is further enriching its portfolio with customization capabilities via customizable gifting options that complement its floral gift options.
  • In February 2023, In February 2023, Lovingly, a leading e-commerce solutions provider for retail florists, acquired Flowers of Charlotte and its wholesale operation, Charlotte Flower Market. This strategic acquisition strengthened Lovingly’s online gifting technology and services, enhancing the support offered to its florist partners.
  • In May 2023, 1-800-FLOWERS.COM acquired SmartGift, Inc. – the gifting platform. The acquisition will add a new capability in corporate gifting and engagement, allowing consumers and businesses alike to enjoy seamless, personalized digital gifting experiences.

 

Why the Subscription Model is Booming in the US Floral Gifting Market

The subscription model is gaining popularity in the US floral gifting market due to several key trends, including growing demand for convenience, personalization, and sustainability. Consumers are increasingly treating special occasions, from birthdays to corporate events, as opportunities to subscribe to floral services. Companies like Flowerbx are tapping into this by offering tailored delivery plans for events.

Sustainability is a significant driver, with brands focusing on biodegradable packaging and sourcing flowers from local farmers to attract environmentally conscious consumers. Subscription models allow for seasonal, fresh flowers with a focus on local sourcing and sustainable practices, which appeals to a growing eco-aware market.

Subscription services also cater to consumers’ desire for personalization, with many companies offering customizable bouquets based on customer preferences. Innovations like “build-your-own” kits and luxury floral options are further enhancing the appeal. Additionally, the rise of zero-waste concepts and eco-friendly disposal methods align with the increasing demand for sustainability, ensuring the subscription model’s continued growth in the floral gifting sector.

 

Looking for More Information? Click: https://www.arizton.com/market-reports/floral-gifting-market-in-united-states-2025

 

Key Company Profiles

  • FTD, LLC
  • 1-800-FLOWERS.COM, INC.
  • Telefora
  • From You Flowers, LLC
  • Avas Flowers
  • Benchmark Bouquets
  • BloomNation, Inc.
  • BloomsyBox
  • Blooms Today
  • Farmgirl Flowers, INC
  • FLoom LTD.
  • Flora2000.com
  • FloraQueen
  • Flowerpetal.com
  • JUST FLOWERS DOT COM
  • The Flower Shop
  • The Bouqs Company
  • UrbanStems
  • Gotham Florist
  • H.Bloom
  • Venus et Fleur
  • Florists.com, LLC
  • 1st in Flowers!, LLC
  • Kremp Florist & Flower Delivery
  • Send Flowers
  • Global Rose
  • Winston Flowers
  • The Sill, INC.
  • Farm Fresh Flowers
  • Enjoy Flowers
  • Freytag’s Florist
  • McShan Florist
  • Phoenix Flower Shops
  • U.S. Retail Flowers Inc.
  • Fifth Ave Floral Co.
  • The Flower Shop Atlanta
  • Phillip’s Flowers & Gifts
  • InBloom Flowers
  • Albuquerque Florist
  • Bokay Florist
  • Flowers4Dreams LLC
  • Flowers of the Field
  • Alyeska Farms
  • Wood’s Flowers and Gifts
  • Azelly Flowers
  • Rainbow Florist & Delectables
  • Roberts Floral & Gifts
  • Petal+Eon
  • Miami Flowers Design
  • Peachtree Petals
  • Crowley House Flower Farm

 

Market Segmentation

 

Occasion

  • Personal & self-gifting,
  • Wedding
  • Corporate
  • Sympathy

 

Platform

  • Offline
  • Online

 

Product

  • Bouquets & Arrangements
  • Stems

 

Purchase Option

  • One-time purchase
  • Subscription

     

What Key Findings Will Our Research Analysis Reveal?      

How big is the U.S. floral gifting market?

What is the growth rate of the U.S. floral gifting market?

What are the significant trends in the U.S. floral gifting market?

Who are the major players in the U.S. floral gifting market?

          

Why Arizton?                                                 

100% Customer Satisfaction                                                 

24×7 availability – we are always there when you need us                                                 

200+ Fortune 500 Companies trust Arizton’s report                                                 

80% of our reports are exclusive and first in the industry                                                 

100% more data and analysis                                                 

1500+ reports published till date                               

                    

Post-Purchase Benefit                                             

1hr of free analyst discussion                                             

10% off on customization                          

                   

About Us:                                                                                      

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services. 

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.  

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.     

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1 3122332770
Country: United States
Website: https://www.arizton.com/market-reports/floral-gifting-market-in-united-states-2025

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The U.S. Floral Gifting Market is Booming Worldwide, $16.81 Billion Worth Market by 2030 – Arizton

Search & Apply to Jobs in a Single Click with AI-powered RoboApply

Packed with innovative features like personalized applications and automatic submissions, the new AI-powered platform is designed to help land dream jobs quickly.

RoboApply is fast becoming a favorite of working professionals around the country who often find themselves buried under endless applications, constantly customizing their resumes and crafting the accompanying cover letters. This new AI-powered platform comes with integration with major online job boards, thus opening up a wide range of opportunities across various industries for professionals at all career stages—from recent graduates to those seeking a career change.

AD_4nXcrlMLN0A5PqKwhXw2c3_AlfjDcr6thgnf_ZrHvKFiZcPOpLTAdl53cxkaYS2Lh1FNZXRaYlJRNt360U8FAMkTb0d1r4V0bZRXAaFRyY9zty1b8A1Lp-0AdvMyr7odpYUiZAktP.png

RoboApply has become a great tool for people looking for a quicker approach to landing their next job at a time when hiring procedures get more digital and competitive. The automated resume and cover letter generator on the platform customizes every application to guarantee every submission resonates with potential employers. RoboApply also helps time-pressed job seekers by providing a one-click application feature, therefore eliminating the need to manually enter data for several job openings.

Available at a starting price of just $19.99 per month, this AI magic tool comes with multi-device access and automated submissions that allow users to apply to unlimited jobs, thus increasing their chances of securing their dream job. Designed to eliminate the most tedious aspects of job hunting, with RoboApply, users can quickly create their profile and upload their resume. Leveraging the power of AI, with just one click, RoboApply analyzes the user’s information and starts applying to hundreds of jobs on popular job boards like LinkedIn, Indeed, ZipRecruiter, Dice, and many more.

What sets RoboApply apart is its intelligent automation. Without any need for managing several spreadsheets or reminders, this complete tracking system lets users remain organized throughout their job search. Furthermore, addressing the difficulties of Applicant Tracking Systems (ATS), the platform automatically optimizes resumes to pass employer screening tools, thus improving candidates’ visibility in highly selective hiring pipelines.

Beyond automation, RoboApply offers expert knowledge and tools to increase interview readiness and confidence. From professional growth to interview preparation, users get useful advice to hone their skills, therefore enabling them to focus on impressing recruiters rather than sorting through documentation.

“Job seekers need smarter tools to stay ahead as the hiring environment gets more digital,” said Idris Aileme, RoboApply’s spokesman. “Our platform lets users concentrate on landing their next opportunity instead of getting bogged down by paperwork, relieving them of the manual effort of job applications.”

RoboApply is truly transforming the way professionals approach the employment market by combining smart automation, strategic optimization, and expert career support—saving time, lowering stress, and greatly raising the likelihood of finding the ideal job.

About RoboApply

RoboApply is an AI-powered job application that helps job seekers maximize their efforts, save critical time, and greatly raise their chances of landing the correct opportunity by automatically creating tailored resumes, automating job applications, and intelligently tracking application progress.

For more information, visit www.robo-apply.com.

Media Contact
Company Name: RoboApply
Contact Person: Idris Aileme
Email: Send Email
Phone: 570-397-4189
State: Texas
Country: United States
Website: https://robo-apply.com/

Inner Strength Counseling Helps Clients Heal from Toxic Relationships, Overcome Anxiety & Build A Life of Confidence

Inner Strength Counseling is led by therapist Catherine Cabrera, licensed in VA, MD, and FL.

Inner Strength Counseling is offering free 20-minute consultations, and strives to help individuals improve their mental health, recover from toxic relationships, overcome anxiety, and lead confident lives.

Inner Strength Counseling is led by Catherine Cabrera, a licensed therapist in Virginia, Maryland, and Florida.

Cabrera specializes in helping patients deal with anxiety, eating disorders, and relationship trauma, with a skillset fitting for highly sensitive people.

“I have a special heart for those living with these challenges because I’ve been in their shoes – I’ve felt trapped by my own thoughts and stuck in an endless cycle of overwhelm and uncertainty, and a survivor of multiple toxic and narcissistic relationships,” Catherine stated.

“I’m a firm believer that everyone has the inner strength to break their cycle and live the life they strive for.”

Cabrera completed her graduate internship working at an eating disorder treatment facility with teens and young adults, after which she began practicing in private practice in 2020 and ultimately opened her practice in October 2022.

She is a Brainz 500 Global Award Recipient and a co-author of multiple books, including “My Mess is My Message II,” “Focus on the Magic,” “I’m So Glad You Left Me,” “and Broken Trust, Healing Hearts.”

Inner Strength Counseling therapy sessions are held virtually through a HIPAA-compliant telehealth platform. Therapies are available to individuals and couples. Before commencing any sessions, all patients are provided with a Good Faith Estimate of the total cost of mental health care.

“I want to help you rediscover your inner strength and support you on your journey,” Catherine tells her patients.

“Whether it’s recovering from an eating disorder, navigating challenges in relationships, or managing depression or anxiety – it’s an ongoing process that doesn’t get easier, you get stronger!”

More information about Inner Strength Counseling and Catherine Cabrera is available on the official website. Catherine is verified by Psychology Today and is active on social media.

Media Contact
Company Name: Inner Strength Counseling, LLC
Contact Person: Catherine Cabrera
Email: Send Email
Country: United States
Website: https://www.innerstrengthcounselingllc.net/